SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-24-004396
Filing Date
2024-03-29
Accepted
2024-03-29 17:18:08
Documents
98
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K nrxp-20231231x10k.htm   iXBRL 10-K 3323235
2 EX-4.8 nrxp-20231231xex4d8.htm EX-4.8 23974
3 EX-4.9 nrxp-20231231xex4d9.htm EX-4.9 64423
4 EX-10.55 nrxp-20231231xex10d55.htm EX-10.55 44063
5 EX-10.60 nrxp-20231231xex10d60.htm EX-10.60 54805
6 EX-10.64 nrxp-20231231xex10d64.htm EX-10.64 250111
7 EX-10.66 nrxp-20231231xex10d66.htm EX-10.66 110572
8 EX-23.1 nrxp-20231231xex23d1.htm EX-23.1 5051
9 EX-31.1 nrxp-20231231xex31d1.htm EX-31.1 12339
10 EX-31.2 nrxp-20231231xex31d2.htm EX-31.2 12616
11 EX-32.1 nrxp-20231231xex32d1.htm EX-32.1 6122
12 EX-32.2 nrxp-20231231xex32d2.htm EX-32.2 6084
13 EX-97.1 nrxp-20231231xex97d1.htm EX-97.1 42889
14 GRAPHIC nrxp-20231231x10k001.jpg GRAPHIC 18032
15 GRAPHIC nrxp-20231231x10k002.jpg GRAPHIC 16852
16 GRAPHIC nrxp-20231231x10k003.jpg GRAPHIC 61447
17 GRAPHIC nrxp-20231231x10k004.jpg GRAPHIC 16218
18 GRAPHIC nrxp-20231231x10k005.jpg GRAPHIC 21179
19 GRAPHIC nrxp-20231231x10k006.jpg GRAPHIC 38579
20 GRAPHIC nrxp-20231231x10k007.jpg GRAPHIC 7523
21 GRAPHIC nrxp-20231231x10k008.jpg GRAPHIC 18166
22 GRAPHIC nrxp-20231231x10k009.jpg GRAPHIC 19407
23 GRAPHIC nrxp-20231231x10k010.jpg GRAPHIC 19012
24 GRAPHIC nrxp-20231231x10k011.jpg GRAPHIC 50034
25 GRAPHIC nrxp-20231231x10k012.jpg GRAPHIC 13438
  Complete submission text file 0001558370-24-004396.txt   10685610

Data Files

Seq Description Document Type Size
26 EX-101.SCH nrxp-20231231.xsd EX-101.SCH 63563
27 EX-101.CAL nrxp-20231231_cal.xml EX-101.CAL 46105
28 EX-101.DEF nrxp-20231231_def.xml EX-101.DEF 248632
29 EX-101.LAB nrxp-20231231_lab.xml EX-101.LAB 427291
30 EX-101.PRE nrxp-20231231_pre.xml EX-101.PRE 412600
102 EXTRACTED XBRL INSTANCE DOCUMENT nrxp-20231231x10k_htm.xml XML 1084736
Mailing Address 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801
Business Address 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801 484-254-6134
NRX Pharmaceuticals, Inc. (Filer) CIK: 0001719406 (see all company filings)

IRS No.: 822844431 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38302 | Film No.: 24804832
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)